Overview
ACON market data
Price History
ACON price chart
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for ACON. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
Aclarion Announces Texas Spine Care Center As New Clinical Site In Chronic Low bAck pain Randomized Independent Trial studY TrialBenzinga · Jul 7, 2026, 11:15 AM
Aclarion Receives Notice Of Allowance For A U.S. Patent On Its Multi-Voxel Prescription For Lumbar Disc EvaluationBenzinga · Jun 24, 2026, 8:05 PM
Aclarion Launches Market Access Program In Partnership With PRIA HealthcareBenzinga · Jun 9, 2026, 11:10 AM
Aclarion Board Reviews Echo Lake's Unsolicited Public Proposal And Unanimously Determined To Reject ItBenzinga · Jun 8, 2026, 11:20 AM
Aclarion Adds Institute of Neuro Innovation to Support Nociscan Growth and Real-World Evidence GenerationGlobenewswire Inc · Jun 3, 2026, 11:15 AM
Aclarion Technology Demonstrates Potential Beyond Surgical Planning in New Immune-Biomarker StudyGlobenewswire Inc · Jun 1, 2026, 11:15 AM
Aclarion Announces That Its Nociscan Technology Was Used In A New Research Study Exploring The Biological Factors Associated With Back Pain In Patients With Modic Type 1 ChangesBenzinga · Jun 1, 2026, 10:04 AM
SentinelOne To Rally Nearly 40%? Here Are 10 Analyst Forecasts For FridayBenzinga · May 29, 2026, 12:33 PM
Ascendiant Capital Maintains Buy on Aclarion, Raises Price Target to $7.5Benzinga · May 29, 2026, 10:42 AM
Aclarion Reviewing Acquisition Offer From Echo Lake Capital For $4/ShareBenzinga · May 28, 2026, 6:51 PM